Top 50 International Biotechnology Trust Plc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| AMGN | AMGEN INC COM | 7.17% | 79.2K | $21.3M | -32.41%(-38.00K) | โ | 2023-09-30 | |
| INCY | INCYTE CORP INC COM | 6.97% | 358.5K | $20.7M | +0.00%(+0) | โ | 2023-09-30 | |
| GILD | GILEAD SCIENCES INC COMMO | 5.9% | 233.6K | $17.5M | +61.56%(+89.00K) | โ | 2023-09-30 | |
| ITCI | INTRA-CELLULAR THERAPIES | 5.57% | 317.9K | $16.5M | +79.73%(+141.00K) | โ | 2023-09-30 | |
| BMRN | BIOMARIN PHARMACEUTICAL I | 4.58% | 153.7K | $13.6M | +161.96%(+95.00K) | โ | 2023-09-30 | |
| SUPN | SUPERNUS PHARMACEUTICALS | 3.96% | 426.5K | $11.8M | -18.53%(-97.00K) | โ | 2023-09-30 | |
| VERA | VERA THERAPEUTICS | 3.5% | 758.4K | $10.4M | -22.24%(-216.87K) | โ | 2023-09-30 | |
| BIIB | BIOGEN INC COMMON STOCK | 3.48% | 40.2K | $10.3M | +265.45%(+29.20K) | โ | 2023-09-30 | |
| HRMY | Harmony Biosciences Holdi | 3.47% | 314.5K | $10.3M | -44.87%(-256.00K) | โ | 2023-09-30 | |
| MRTX | MIRATI THERAPEUTICS INC C | 3.17% | 216.0K | $9.4M | -16.92%(-44.00K) | โ | 2023-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | โ | โ | โ | โ |
| Top 20 Holdings Unweighted | โ | โ | โ | โ |
International Biotechnology Trust Plc reports $296.85M in US-listed equity holdings across 65 positions in its most recent 13F filing. Its largest disclosed positions are AMGN (7.2%), INCY (7.0%) and GILD (5.9%). Figures reflect the Q3 2023 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track International Biotechnology Trust Plc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from International Biotechnology Trust Plcโs Form 13F filings with the U.S. Securities and Exchange Commission (CIK 942257). View International Biotechnology Trust Plcโs 13F filings on SEC